![](/img/cover-not-exists.png)
The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine
Xiu, Cai, Li, Xiao, Wu, Lingyun, Xu, Feng, He, Qi, Zhang, Zheng, Wu, Dong, Song, Luxi, Su, Jiying, Zhou, Liyu, Zhao, Youshan, Tao, Ying, Chang, ChunkangJournal:
Journal of Cancer Research and Clinical Oncology
DOI:
10.1007/s00432-019-03031-w
Date:
September, 2019
File:
PDF, 912 KB
2019